Epelsiban - CISMeF

Preferred Label : Epelsiban;

NCIt synonyms : 2,5-piperazinedione, 3-(2,3-dihydro-1h-inden-2-yl)-1-((1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl)-6-((1S)-1-methylpropyl)-, (3R,6R)-; (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-((1R)-1-(2,6-dimethylpyridin-3-yl)-2-(morpholin- 4-yl)-2-oxoethyl)-6-((1S)-1-methylpropyl)piperazine-2,5-dione;

UNII : T2EZ19HX73;

InChIKey : UWHCWRQFNKUYCG-QUZACWSFSA-N;

CAS number : 872599-83-2;

Molecule name : GSK-557296;

Chemical formula : C30H38N4O4;

Détails

Origin ID

C99151;

UMLS CUI

C3274566;

Currated CISMeF NLP mapping
- epelsiban [MeSH concept]
- epelsiban [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- epelsiban [MeSH Supplementary Concept]
- epelsiban [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Epelsiban Besylate [NCIt concept]
is_free_acid_or_base_form_of
- Epelsiban Besylate [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients